Effect of Kron (Citicoline and Nicotinamide Oral Solution) on Patients With Open-angle Glaucoma - Trial NCT06333236
Access comprehensive clinical trial information for NCT06333236 through Pure Global AI's free database. This phase not specified trial is sponsored by ASST Santi Paolo e Carlo and is currently Not yet recruiting. The study focuses on Glaucoma. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
ASST Santi Paolo e Carlo
Timeline & Enrollment
N/A
Mar 25, 2024
Nov 30, 2024
Primary Outcome
Electrofunctional evaluation
Summary
Aim of this study is to investigate the administration effects of the combination of
 citicoline 40mg/ml and nicotinamide 15mg/ml oral solution (Kron®) on short term improvement
 in inner retinal function, bioelectrical activity of the visual cortex and visual function.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06333236
Non-Device Trial